Pharma Empagrow Duo Tablet 5/850 Milligrams (Empagliflozin, Metformin Hydrochloride)

Adult dose

The recommended dosage of this medication is 1 tablet, twice daily. The dose should be determined considering the individual patient's treatment regimen, efficacy, and tolerability, not exceeding Empagliflozin 25 mg and Metformin 2000 mg. In cases where adequate blood sugar control is not achieved with Metformin alone or in combination with other medications such as insulin, the recommended dosage is Empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the current dose of Metformin.

This medication can cause rare but serious side effects such as severe lactic acidosis and should not be used by patients with impaired kidney function. Caution is needed as there is a risk of hypoglycemia when used with other diabetes medications. Patients with moderate to severe renal impairment, acute kidney problems, heart failure, acute myocardial infarction, and other serious conditions should not take this medication. Patients scheduled for tests involving iodine contrast agents must discontinue this medication before and after the test and can resume once kidney function is confirmed as normal. Women who are pregnant or breastfeeding should not use this medication, and it is not recommended for children. Side effects like hypoglycemia, urinary tract infections, genital infections, increased urination may occur; if any unusual symptoms appear, consult a doctor immediately. Elderly patients or those with dehydration risk must ensure adequate fluid intake and regular monitoring of their condition while taking this medication. Patients with impaired liver function or those consuming excessive alcohol should also avoid using this medication. While this medication helps control blood sugar, regular blood tests and monitoring of kidney function are important for safe use. Hypoglycemic symptoms can occur, so especially when taken with insulin or sulfonylureas, blood sugar levels should be monitored closely. If surgery or an acute illness occurs during treatment, consult a doctor about temporarily stopping the medication. It is advisable to avoid alcohol consumption during treatment and to check vitamin B12 levels regularly. Any unusual symptoms or discomfort during medication should be reported to healthcare professionals, and one should not discontinue or alter treatment without consultation.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormality accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities, sudden and severe headaches, thunderclap headaches, seizures.

Mild side effects

• Hypoglycemia
• urinary tract infections
• genital infections
• increased urination
• nausea
• vomiting
• diarrhea
• abdominal pain
• loss of appetite
• constipation

This medication must be stored in a tightly sealed container to avoid exposure to air or moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius to ensure the medication's efficacy.

Appearance

White, oval, biconvex film-coated tablet with a yellowish tint.

Package unit

10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle